Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the challenges of managing side effects from immunotherapy treatments.
Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the challenges of managing side effects from immunotherapy treatments.
Davies says many of the treatments being developed and tested are immunotherapies. These therapies bring with them a new constellation of possible side effects and symptoms that are very different than the standard chemotherapy side effects nurses are used to.
It is important to educate nurses and primary care physicians, Davies says, but this continues to be a challenge.
Switch Maintenance Regimens Demonstrate Similar Efficacy for Patients with RAS Wild-Type mCRC
ASH Data Offer Treatment Direction for Oncology Nursing Professionals
HRQOL Analysis Favors Tislelizumab Over Sorafenib in Hepatocellular Carcinoma
Encorafenib Triplet Elicits Antitumor Activity in BRAF V600E+ mCRC
2 Clarke Drive
Cranbury, NJ 08512